News

Gujarat Inject (Kerala) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 August 2026.

Net profit of Gujarat Inject (Kerala) rose 1685.71% to Rs 1.25 crore in the quarter ended June 2026 as against Rs 0.07 crore during the previous quarter ended June 2025. Sales rose 414.46% to Rs 12.45 crore in the quarter ended June 2026 as against Rs 2.42 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales12.452.42 414 OPM %13.573.72 - PBDT1.690.09 1778 PBT1.690.09 1778 NP1.250.07 1686 Powered by Capital Market - Live News

Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 15 July 2026.

Net profit of Gujarat Inject (Kerala) rose 2242.86% to Rs 1.64 crore in the quarter ended March 2026 as against Rs 0.07 crore during the previous quarter ended March 2025. Sales rose 624.06% to Rs 30.70 crore in the quarter ended March 2026 as against Rs 4.24 crore during the previous quarter ended March 2025.For the full year,net profit rose 77.45% to Rs 1.81 crore in the year ended March 2026 as against Rs 1.02 crore during the previous year ended March 2025. Sales rose 90.66% to Rs 36.32 crore in the year ended March 2026 as against Rs 19.05 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales30.704.24 624 36.3219.05 91 OPM %7.392.12 -6.335.67 - PBDT2.270.10 2170 2.501.26 98 PBT2.270.10 2170 2.501.26 98 NP1.640.07 2243 1.811.02 77 Powered by Capital Market - Live News

Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 20 May 2026.